Michael Roden

71.6k total citations · 20 hit papers
702 papers, 33.0k citations indexed

About

Michael Roden is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Michael Roden has authored 702 papers receiving a total of 33.0k indexed citations (citations by other indexed papers that have themselves been cited), including 258 papers in Physiology, 252 papers in Endocrinology, Diabetes and Metabolism and 213 papers in Epidemiology. Recurrent topics in Michael Roden's work include Liver Disease Diagnosis and Treatment (141 papers), Adipose Tissue and Metabolism (117 papers) and Diet and metabolism studies (113 papers). Michael Roden is often cited by papers focused on Liver Disease Diagnosis and Treatment (141 papers), Adipose Tissue and Metabolism (117 papers) and Diet and metabolism studies (113 papers). Michael Roden collaborates with scholars based in Germany, Austria and United States. Michael Roden's co-authors include Gerald I. Shulman, Christian Herder, Julia Szendroedi, P. Nowotny, W. Waldhäusl, Douglas L. Rothman, Martin Krššák, Tomáš Jeleník, Gary W. Cline and Michael Krebs and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael Roden

653 papers receiving 32.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanism of free fatty acid-induced insulin resistance in humans.

1996 1.2k citations Michael Roden et al. profile →
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study

1999 996 citations Michael Roden et al. Diabetologia profile →
Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions

2011 826 citations Michael Roden et al. profile →
The integrative biology of type 2 diabetes

2019 765 citations Michael Roden et al. profile →
Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach

2012 755 citations Martin Hrabě de Angelis, Annette Peters et al. profile →
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis

2015 752 citations Chrysi Koliaki, Julia Szendroedi et al. profile →
NAFLD and diabetes mellitus

2016 751 citations Michael Roden et al. profile →
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

2024 585 citations Michael Roden et al. profile →
The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments

2021 553 citations Michael Roden et al. profile →
Increased Glucose Transport–Phosphorylation and Muscle Glycogen Synthesis after Exercise Training in Insulin-Resistant Subjects

1996 520 citations Michael Roden et al. profile →
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors

2020 228 citations Michael Roden et al. profile →
Mitochondrial alterations in fatty liver diseases

2022 215 citations Michael Roden et al. profile →
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans

2020 212 citations Kalliopi Pafili, Michael Roden profile →
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

2025 170 citations Michael Roden et al. profile →
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus

2023 121 citations Michael Roden et al. Nature Reviews Endocrinology profile →
Diabetes mellitus – Definition, Klassifikation, Diagnose, Screening und Prävention (Update 2023)

2023 101 citations Michael Roden et al. profile →
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial

2024 63 citations Michael Roden et al. profile →
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

2024 62 citations Michael Roden, S. Kahl et al. profile →
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary

2024 47 citations Michael Roden et al. Diabetologia profile →
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance

2025 14 citations Maria Apostolopoulou, Michael Roden et al. profile →

Peers

Countries citing papers authored by Michael Roden

Since Specialization

Citations

This map shows the geographic impact of Michael Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Roden more than expected).

Fields of papers citing papers by Michael Roden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Roden. The network helps show where Michael Roden may publish in the future.

Co-authorship network of co-authors of Michael Roden

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Roden. A scholar is included among the top collaborators of Michael Roden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Roden. Michael Roden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A web-based application for diabetes subtyping: The DDZ Diabetes-Cluster-Tool 2025 ·Acta Diabetologica ·(unknown), Katsiaryna Prystupa, Klaus Straßburger, Mischa Bonn, Oana‐Patricia Zaharia, (unknown), Oliver Kuß, Michael Roden, Róbert Wágner	4
2	Prediction Model for Polyneuropathy in Recent‐Onset Diabetes Based on Serum Neurofilament Light Chain, Fibroblast Growth Factor‐19 and Standard Anthropometric and Clinical Variables 2024 ·Diabetes/Metabolism Research and Reviews ·Haïfa Maalmi, (unknown), (unknown), Gidon J. Bönhof, Wolfgang Rathmann, Dan Ziegler, Michael P. Menden, Michael Roden, Christian Herder, (unknown)	0
3	Semaphorin-3A regulates liver sinusoidal endothelial cell porosity and promotes hepatic steatosis 2024 ·Nature Cardiovascular Research ·Daniel Eberhard, (unknown), (unknown), (unknown), (unknown), Philipp Niklas Ostermann, Philip Kirschner, (unknown), (unknown), (unknown), Sandra Trenkamp, Bengt‐Frederik Belgardt, Timo Dickscheid, Iréne Esposito, Michael Roden, Eckhard Lammert	8
4	The Journey to a FAIR CORE DATA SET for Diabetes Research in Germany 2024 ·Scientific Data ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andreas L. Birkenfeld, Martin Hrabě de Angelis, Michael Roden, Atinkut Alamirrew Zeleke, (unknown), Dagmar Waltemath	2
5	The sugar-free paradox: cardiometabolic consequences of erythritol 2023 ·Signal Transduction and Targeted Therapy ·Kalliopi Pafili, Michael Roden	2
6	SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction 2023 ·BMC Cardiovascular Disorders ·Florian Bönner, Christian Jung, Amin Polzin, Ralf Erkens, Lisa Dannenberg, (unknown), (unknown), (unknown), (unknown), Oana‐Patricia Zaharia, Christian Meyer, Ulrich Flögel, Bodo Levkau, Axel Gödecke, Jens W. Fischer, (unknown), Martina Krüger, Michael Roden, Malte Kelm	2
7	Inter-organ crosstalk during development and progression of type 2 diabetes mellitus breakdown → 2023 ·Nature Reviews Endocrinology ·(unknown), (unknown), Michael Roden	121
8	Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases 2023 ·EBioMedicine ·Bedair Dewidar, Lucia Mastrototaro, (unknown), Claudia Ress, Cesare Granata, (unknown), Dominik Pesta, (unknown), Martin Wolkersdorfer, Iréne Esposito, (unknown), (unknown), Aslihan Yavas, Michael Roden	28
9	Early life factors and their relevance for markers of cardiometabolic risk in early adulthood 2021 ·Nutrition Metabolism and Cardiovascular Diseases ·(unknown), (unknown), Janina Goletzke, (unknown), Christian Herder, Michael Roden, Stefan A. Wudy, (unknown), Thomas Remer, Anette E. Buyken	1
10	Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis 2021 ·Diabetologia ·Sabrina Schlesinger, Manuela Neuenschwander, Alexander Lang, Kalliopi Pafili, Oliver Kuß, Christian Herder, Michael Roden	61
11	Metabolic responsiveness to training depends on insulin sensitivity and protein content of exosomes in insulin-resistant males 2021 ·Science Advances ·Maria Apostolopoulou, Lucia Mastrototaro, Sonja Hartwig, Dominik Pesta, Klaus Straßburger, Elisabetta De Filippo, Tomáš Jeleník, Yanislava Karusheva, Sofiya Gancheva, Daniel F. Markgraf, Christian Herder, K. Sreekumaran Nair, Andreas S. Reichert, Stefan Lehr, Karsten Müssig, Hadi Al‐Hasani, Julia Szendroedi, Michael Roden	30
12	Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population 2021 ·Nephrology Dialysis Transplantation ·Jana Nano, Ben Schöttker, Jie-sheng Lin, Cornelia Huth, Mohsen Ghanbari, (unknown), Haïfa Maalmi, Stefan Karrasch, Wolfgang Köenig, Dietrich Rothenbacher, Michael Roden, Christa Meisinger, Annette Peters, Hermann Brenner, Christian Herder, Barbara Thorand	15
13	Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study 2020 ·Cardiovascular Diabetology ·Cornelia Huth, (unknown), Astrid Zierer, (unknown), Christa Meisinger, Michael Roden, Annette Peters, Wolfgang Köenig, Christian Herder, Barbara Thorand	20
14	Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance 2020 ·JCI Insight ·Theresia Sarabhai, S. Kahl, Julia Szendroedi, Daniel F. Markgraf, Oana‐Patricia Zaharia, Cristina Barosa, Christian Herder, (unknown), Pavel Bobrov, Jonghee Hwang, John G. Jones, Michael Roden	23
15	Reversion from prediabetes to normoglycaemia after weight change in older persons: The KORA F4/FF4 study 2020 ·Nutrition Metabolism and Cardiovascular Diseases ·Bernd Kowall, Wolfgang Rathmann, Oliver Kuß, Christian Herder, Michael Roden, Andreas Stang, Cornelia Huth, Barbara Thorand, Christa Meisinger, Annette Peters	11
16	Athletes feature greater rates of muscle glucose transport and glycogen synthesis during lipid infusion 2019 ·JCI Insight ·Esther Phielix, Paul Begovatz, Sofiya Gancheva, Alessandra Bierwagen, Esther Kornips, Gert Schaart, Matthijs K. C. Hesselink, Patrick Schrauwen, Michael Roden	8
17	Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis 2018 ·Diabetes Care ·Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki, (unknown), Tomáš Jeleník, Elisabetta De Filippo, Christian Herder, Daniel F. Markgraf, Frank Jankowiak, Iréne Esposito, Matthias Schlensak, (unknown), Michael Roden	211
18	Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study 2018 ·European Journal of Epidemiology ·Cornelia Huth, Christine von Toerne, (unknown), Tonia de las Heras Gala, Christian Herder, Florian Kronenberg, Christa Meisinger, Wolfgang Rathmann, Wolfgang Köenig, Mélanie Waldenberger, Michael Roden, Annette Peters, Stefanie M. Hauck, Barbara Thorand	39
19	Acceleration of the interleukin-1 receptor antagonist (IL-1Ra) trajectory precedes the diagnosis of type 2 diabetes by 6 years: the Whitehall II prospective cohort study 2009 ·UCL Discovery (University College London) ·Maren Carstensen, (unknown), Mika Kivimäki, Markus Jokela, Michael Roden, (unknown), (unknown), Eric J. Brunner, Ádám G. Tabák	1
20	Thiazolidinediones Influence Plasma Steroids of Male Obese Zucker Rats 2002 ·Endocrinology ·Clemens Fürnsinn, P. Nowotny, Barbara Brunmair, (unknown), Michael Roden, W. Waldhäusl, H. Vierhapper	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact